GlassScriptPhysician profile
Steven T Richey
NPI 1417953050
$2,092.01
in general payments reported to CMS, 2019-2025
19 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2021: $104 · 2022: $371 · 2023: $511 · 2024: $628 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $744.25 | 2023-2025 | Monoferric |
| Boston Scientific Corporation | $538.83 | 2019-2025 | Patient Trial Kit, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $179.46 | 2019 | |
| US Oncology Corporate, INC. | $118.08 | 2024 | |
| Onmark, INC. | $86.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.69 | 2022-2025 | Relistor |
| Medtronic, INC. | $68.34 | 2024 | Emprint |
| Collegium Pharmaceutical, INC. | $44.74 | 2019-2024 | Belbuca |
| Nevro Corp. | $40.76 | 2019 | |
| Abbvie INC. | $40.07 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $29.49 | 2021 | |
| Si-Bone, INC. | $25.81 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.39 | 2022 | |
| Stimwave Technologies Incorporated | $17.52 | 2022 | |
| Mdd US Operations, LLC | $14.37 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $13.66 | 2023 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $12.79 | 2019 | |
| Sentynl Therapeutics, INC. | $11.64 | 2019 | |
| Grt US Holding, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Richey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.